Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Press Release - Coventry Connect Claim Profile
Experts Say Identify Comorbidities Early to Control Workers’ Comp Claims Costs
Unaddressed comorbid conditions can significantly complicate recovery and inflate claims costs. Industry experts emphasize the importance of early identification and intervention to improve outcomes, reduce disability duration, and control spending. Learn why proactive clinical strategies are essential for effective claims management.
StateWatch Fall 2016
Genex Services Acquires OMAC - Leading IME Provider in Pacific Northwest
Acquisition Strengthens Genex IME/Peer Review Network & Offering
Case Severity: What Factors are You Missing in Delayed RTW Cases?
Case severity tools like the ODG calculator play a big role in helping workers’ comp professionals predict return-to-work timing and costs based on the total claim picture. However, if you fail to look beyond the compensable diagnosis, you may find that your severity rating score doesn’t add up. Genex’s Mariellen Blue, RN, CCM, national director of case management services, explains in this podcast.
WorkCompWire: Mariellen Blue: Factoring Comorbidities Into Case Severity
In her article, "Factoring Comorbidities Into Case Severity," Mariellen Blue, RN, CCM, National Director of Case Management at Genex Services, discusses the significant impact of comorbid conditions—such as obesity, diabetes, hypertension, depression, and substance abuse—on workers' compensation claims.